Pharmacists Perspective Faryal Faisal, PharmD Mounjaro and Ozempic are diabetes-approved brands
Imaging of 20 days adult flies showed the neuronal architecture of Sp treated park 13 flies similar to the wild type controls whereas their untreated counterparts showed shrinkage, aggregation, and complete disruption of dopaminergic neural networks (Fig

GLP-1 450-750 GLP-1 - 1 2 T2D 450-750 GLP-1 30%-50% 20351500 GLP-1 20%-25% 30%-50% 450-750 GLP-1 2025 danuglipron orforglipron 20 + GLP-1 6 / Kailera15 + GLP-1 + HDM1002 HRS-7535 III orforglipron 1-2 Regor RGT-075 I/II 10%-30% GLP-1 1 GLP-1 BD 120+ GLP-1 III 6 HRS-7535/HRS-9531 NewCo HS-10535 2025 SYH2086 Madrigal2026 20 15+ HDM1002 III IBI3032 I TQF3250 IND BD Regor RGT-075 IIb 202512 2 BD + GLP-1 2030 61%34%2024-2025 4 - - GLP-1 orforglipron 188.8 137.65 / 2 GLP-1 1 orforglipron orforglipronIII 36mg 72 T2D 9.1%-11.5% 10.3% 25mgIII 64 11% 7% HRS-7535180mg 36 BMI 32.5 37-39 8.0%Regor RGT-075125mg IIa 12 5.0% 2 / + MindRank MDR-001240mg 43.8% HRS-7535180mg 43.8% orforglipron10.3% Regor RGT-075 danuglipronScaffold B Scaffold B HDM1002 800 2026 I 3 - + orforglipron OSAIII / T2D HRS-7535 + HFpEFII Scaffold B GLP-1 Scaffold Aorforglipron Scaffold Bdanuglipron Scaffold B HDM1002 Scaffold A 10%-30% orforglipron danuglipron - Kailera - FTO GLP-1 III 17.5% 20.9% CDMO GLP-1 1 600276.SS/1276.HK NewCo HRS-7535/HRS-9531 6 B 19.9% + royalties III 2026 180mg 8.0% 3692.HKHS-10535 2025 HS-10501 II 2026 II 1093.HKSYH2086 Madrigal2026 + MASH Madrigal 2 BD000963.SZHDM1002 GLP-1 III 2026 Scaffold B GLP-1/GIP DR10624MASH II 1801.HKIBI3032 I preclinical 5-10 2026 I BD 1177.HKTQF3250orforglipron IND2026 I / T2D 3CDMO GLP-1 CDMO 2269.HK CDMO 23 GLP-1 24%2025 TIDES / 142% GLP-1 GLP-1 30%-40% III danuglipron 2025 12 Regor RGT-075 IIb 2026 / III Scaffold A 2027 GLP-1 50%+ GLP-1 GLP-1 450-750 III / I CDMO 2025 12 Regor IIb 2026 / III ()

Rybelsus is a prescription glucagon-like peptide-1 (GLP-1) receptor agonist used to manage blood sugar levels in people with type 2 diabetes
Cells were lysed by sonication using a Qsonica sonicator with an amplitude of 40% for 10 minutes total (10 s on, 10 s off)
Gavin LA, Moeller M, Shoback D, Cavalieri RR